-
Information-Publications
-
PDTAC: Targeted photodegradation of GPX4 triggers Ferroptosis and potent antitumor immunityDetails
-
Chronic exposure to the gibberellin derivative GA‑13315 sensitizes breast cancer MCF‑7 cells but not colon cancer HCT116 cells to irinotecanDetails
-
New perspectives on the potential of tetrandrine in the treatment of non-small cell lung cancer: bioinformatics, Mendelian randomization study and …Details
-
Structure-based discovery of a new series of nucleoside-derived ring-opening PRMT5 inhibitorsDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands